RCUS Stock Analysis: Buy, Sell, or Hold?
RCUS - Arcus Biosciences, Inc.
$20.76
0.48 (2.37%)
▲
5d:
-3.04%
30d:
+1.91%
90d:
-10.09%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
RCUS is down 8.9% this week, but smart money is accumulating calls. Top strike: $22.5 2026-04-17 with 604 OI. Call ratio: 94% View Scanner →
Strength: 8.9/10
Get Alerted When RCUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RCUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: RCUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: RCUS is currently trading at $20.76, which is considered slightly low relative to its 30-day fair value range of $19.72 to $23.15.
Technical Outlook: Technically, RCUS is showing sideways momentum. Immediate support is located at $20.00, while resistance sits at $23.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.80 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RCUS is showing sideways momentum. Immediate support is located at $20.00, while resistance sits at $23.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.80 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$19.72 -
$23.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.7% below Wall St target ($33.80)
Fair Price Analysis
30-Day Fair Range
$19.72 -
$23.15
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$20.00
Resistance Level
$23.16
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.81
Wall Street Target
$33.80
(+66.7%)
Revenue Growth (YoY)
26.9%
Profit Margin
-142.9%
Share & Embed Analysis
Last updated: March 30, 2026 12:18 PM ET
Data refreshes hourly during market hours. Next update: 1:18 PM
Data refreshes hourly during market hours. Next update: 1:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Juan C Jaen
SELL
31823 shares
2026-01-05
Robert C Goeltz II
SELL
6552 shares
2025-12-31
Alexander Azoy
SELL
4343 shares
2025-12-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 61 BUY |
Advanced RCUS Option Strategies
Professional options setups generated by AI based on today's RCUS price and gamma walls.
